The Stem Cell Differentiation Core provides patient-specific, stem cell-based models that enable investigators to test CFTR function and its rescue through various approaches including, but not ...
Over the past five years, the FCSC has invested $3.5 million in replacing or updating its instruments, expanding capacity, and developing new services such as multiplex immunofluorescence, Hanumanthu ...
DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb Genomics, a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ...
BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME ™ Whole Genome and Transcriptome Single-Cell Core Kit ...
Combines BioSkyrb’ s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384- well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results